Eli Lilly and Co. has agreed to buy Hypnion Inc., a Lexington, Mass., neuroscience drug research firm focused on sleep disorder. Financial terms were not disclosed. The acquisition is expected to close by the end of the month.
A bill weaving its way through the Indiana General Assembly could give the state an edge in attracting and growing the type of high-tech ventures several states covet. Indiana House Bill 1461, introduced by Rep. Brian Bosma, R-Indianapolis, advanced to the Senate after sailing through the House of Representatives on Feb. 26 by a vote of 95-3. The legislation that was referred to the Senate’s Economic Development and Technology Committee would provide a tax incentive that would shield income from…
Recently, I attended a Stanley K. Lacy Leadership Seminar at the Downtown Marriott. Members of the socalled “City Committee”-a group that convened three decades ago to brainstorm and map the future of India n a p o l i s – w e r e addressing younger professionals who well could be involved in determining the direction for our city over the next 30 years. Louis Mahern, who was then a leading state Democratic senator helping to push bipartisan support…
The state of Montana has sued Eli Lilly and Co. for marketing its Zyprexa antipsychotic drug for off-label uses—the seventh state to make such claims. The lawsuit alleges the Indianapolis drugmaker owes the state for drug costs and harming patients after promoting the drug to sedate nursing home patients and giving kickbacks to doctors, according […]
Safety jitters will cause sales of Eli Lilly and Co.’s Zyprexa schizophrenia drug to stop growing this year and stabilize at 2006 levels, CEO Sidney Taurel told reporters yesterday following a meeting at the Chief Executive’s Club at Boston College. The blockbuster drug has been blamed for weight gain and triggering diabetes in some patients. […]
Eli Lilly and Co. is among 11 companies singled out by the mammoth California Public Employee Retirement System for “dismal stock performance” and poor corporate governance, according to Bloomberg. Lilly landed on Calpers’ annual “Focus List” for not allowing shareholders to amend company bylaws and by having tiers of board members that prevent the board […]
Shrinking advertising revenue has persuaded the owners of Indy Men’s Magazine to stop publishing the free, glossy monthly after five years. Publisher Todd Tobias said the final, May issue will be distributed in late April: “As a monthly print publication, we’re done,” he said. Magazine parent Table Moose Media LLC is owned by Tobias, his […]
It seemed like a feel-good story for the ages. Heiress Ruth Lilly’s estimated $185 million gift to two fledgling arts groups made headlines around the globe when the news broke five years ago. Then events took a dramatic turn. The organizations-the Chicago-based Poetry Foundation and the Washington, D.C.-based Americans for the Arts-charged their fortunes should be far larger. They sued National City Bank of Indiana, alleging it bungled management of Lilly’s assets, costing them tens of millions of dollars. A…
The team leading Indianapolis’ bid to host the 2011 Super Bowl is calling on the corporate community to get in the game fast.
More than a dozen business leaders are rushing to raise $25 million before May 23, when NFL owners are expected to select
a host city from hopefuls Indianapolis; Dallas; and Glendale, Ariz.
Sometimes it’s hard to tell who hates performance reviews more-managers or employees. But what if the timeworn paper-based annual assessment were replaced with a Web-based process that allows managers to consistently evaluate employees’ skills against company goals? Indianapolis-based Bowland Solutions has come up with just such an alternative, and it has helped the firm build a client roster that includes heavyweights like international banking giant HSBC, music purveyor Virgin Megastores, global pharmaceutical firm GlaxoSmithKline and Earthbound Farm, North America’s largest…
The president of Terre Haute Economic Development Corp. wants to look deeper into Pfizer Inc.’s troubles with its new inhaled insulin before Vigo County officials complete their offer of $4.5 million in tax-increment finance incentives for the plant that makes the product. Steve Witt told the County Council it would be “good business” to learn […]
A big question is looming for property managers at National City Center and First Indiana Plaza: Will tenants stay or will they go? Each of the downtown office buildings already is struggling, with occupancy rates in the 60-percent range at the end of 2006. But a grim situation could worsen if some of their largest tenants with expiring leases find a better deal elsewhere. Law firm Bose McKinney & Evans is considering a move from 80,000 square feet at First…
Most central Indiana HMOs lost customers again in 2006, with consumerdriven health care plans inflicting the latest cut. Eight out of 10 major health maintenance organizations lost members, some for a third straight year. The declines ranged from 4 percent to 48 percent, according to their annual reports filed with the Indiana Department of Insurance. Most HMOs are in no danger of going out of business. Many posted increased profit in 2006, and most have healthy cash reserves. But HMOs…
One of the most enjoyable aspects of my job as president of the Indiana Economic Development Corp. and secretary of commerce was the opportunity to represent our governor and the state of Indiana on goodnews occasions. On April 26, 2005, I bestowed official state certification on Intech Park, a business incubator that had qualified under the Indiana Certified Technology Park Program. Certified tech parks enjoy the advantage of being allowed to capture and invest in the development of their park…
When I was promoted to president and chief operating officer of our firm a couple of years ago, I was not totally aware that directing a staff in a service business has special requirements you can’t appreciate until you are actually in the role. I assumed that I would go on working Fortunately, my company has a board of directors that includes Tim Baldwin, a management professor at Indiana University’s Kelley School of Business. His counsel has been invaluable in…
The European Medicines Agency has granted Eli Lilly and Co.’s enzastaurin drug “orphan” status—a decade of marketing exclusivity for drugs aimed at serious, rare illnesses. As a result, the Indianapolis drugmaker is ramping up a late-stage clinical trial of the oral agent, which is designed to limit relapses in patients with a type of non-Hodgkin’s […]
California Public Employees’ Retirement System has sent letters to Eli Lilly and Co.’s 1,600 largest shareholders seeking support for a proxy resolution that would require only a majority vote by shareholders to amend its bylaws, Bloomberg reports. The Indianapolis drugmaker requires a supermajority of shareholders, which Calpers says restricts change and ultimately retards stock prices. […]
Eli Lilly and Co. weighed in against a proposed constitutional amendment to ban same-sex marriage in Indiana in a letter sent to Speaker of the House B. Patrick Bauer, D-South Bend. Lilly joined three other major Indiana employers that have voiced opposition to the amendment. Representatives of Cummins Inc. and WellPoint Inc. testified before a […]
A Parkinson’s disease medication originally developed and sold by Eli Lilly and Co. has been voluntarily pulled from the U.S. market after the Food and Drug Administration reviewed new information that associates it with heart problems. Pergolide, which Lilly sold under the Permax brand, has been licensed to the Aliso Viejo, Calif., drugmaker Valeant Pharmaceuticals […]
Pfizer Inc.’s new inhaled insulin product, Exubera, has stumbled out of the gate. That would appear to keep the door open
for Eli Lilly and Co., as well as for other companies racing to develop inhaled insulin. But Pfizer’s troubles might cause
doctors and patients to sour on all inhaled insulin products.
